The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Issues
Latest issue
Regular issues
Supplements
PCR Trials
All issues
Articles
Regular articles
Ahead of print
All articles
Topics
Coronary interventions
STEMI
NSTEMI
Stable CAD
Stents and scaffolds
Left main and multivessel disease
Bifurcation lesions
CTO
Other coronary interventions
Interventions for valvular disease
TAVI
Mitral valve replacement and repair
Tricuspid / Pulmonary valve
Other valvular and structural interventions
Interventions for heart failure
Acute heart failure
Chronic heart failure
Peripheral interventions
Below the knee
Abdominal aortic aneurysm
Iliac / Femoral / Popliteal
Other peripheral interventions
Interventions for hypertension
Renal artery angioplasty
Renal denervation
Other hypertension
Interventions for stroke
Carotid stenting
LAA closure
Ischaemic stroke
Other stroke interventions
Services
Subscribe
Advertise
Rights & permissions
Reprint-Eprint
Join our mailing list
About
Overview
Editorial board
Contact us
Author centre
Michael A. Borger
Showing 1-10 of 10 articles
Transcatheter aortic valve implantation versus surgical aortic valve replacement in patients at low to intermediate surgical risk: rationale and design of the randomised DEDICATE Trial
Seiffert M,
Vonthein R,
Baumgartner H,
Borger MA,
Choi Y,
Falk V,
Frey N,
Hagendorff A,
Hagl C,
Hamm C,
König IR,
Landmesser U,
Massberg S,
Reichenspurner H,
Thiele H,
Twerenbold R,
Vens M,
Walther T,
Ziegler A,
Cremer J,
Blankenberg S
October 23, 2023 | 10.4244/EIJ-D-23-00232
TAVI in younger patients with bicuspid aortic stenosis: pros and cons
Blackman D,
Ali N,
Borger MA
November 18, 2022 | 10.4244/EIJ-E-22-00042
Impact of moderate or severe left ventricular outflow tract calcification on clinical outcomes of patients with severe aortic stenosis undergoing transcatheter aortic valve implantation with self- and balloon-expandable valves: a post hoc analysis from the SOLVE-TAVI trial
Farhan S,
Stachel G,
Desch S,
Kurz T,
Feistritzer H,
Hartung P,
Eitel I,
Nef H,
Doerr O,
Lauten A,
Landmesser U,
Sandri M,
Holzhey D,
Borger MA,
Ince H,
Öner A,
Meyer-Saraei R,
Wienbergen H,
Fach A,
Frey N,
de Waha-Thiele S,
Thiele H
October 21, 2022 | 10.4244/EIJ-D-22-00156
Transcatheter edge-to-edge mitral valve repair with the PASCAL system: early results from a real-world series
Besler C,
Noack T,
von Roeder M,
Kitamura M,
Kresoja K,
Flo Forner A,
Bevilacqua C,
Desch S,
Ender J,
Borger MA,
Thiele H,
Lurz P
November 20, 2020 | 10.4244/EIJ-D-20-00216
Systematic use of intentional leaflet laceration to prevent TAVI-induced coronary obstruction: feasibility and early clinical outcomes of the BASILICA technique
Kitamura M,
Majunke N,
Holzhey D,
Desch S,
Bani Hani A,
Krieghoff C,
Gutberlet M,
Protsyk V,
Ender J,
Borger MA,
Dvir D,
Thiele H,
Abdel-Wahab M
October 23, 2020 | 10.4244/EIJ-D-20-00386
Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis: the three-year results of the PEPCAD II ISR study
Unverdorben M,
Vallbracht C,
Cremers B,
Heuer H,
Hengstenberg C,
Maikowski C,
Werner G,
Antoni D,
Kleber F-X,
Bocksch W,
Leschke M,
Ackermann H,
Borger MA,
Speck U,
Degenhardt R,
Scheller B
December 20, 2015 | 10.4244/EIJY14M08_12
Transcatheter mitral valve-in-ring with the Melody prosthesis: a new therapeutic opportunity
Borger MA,
Kodali SK
December 22, 2014 | 10.4244/EIJV10I8A156
Treatment of small coronary arteries with a paclitaxel-coated balloon catheter in the PEPCAD I study: are lesions clinically stable from 12 to 36 months?
Unverdorben M,
Kleber F-X,
Heuer H,
Figulla HR,
Vallbracht C,
Leschke M,
Cremers B,
Hardt S,
Buerke M,
Ackermann H,
Borger MA,
Degenhardt R,
Scheller B
September 27, 2013 | 10.4244/EIJV9I5A99
Treatment of bifurcation lesions with a drug-eluting balloon: the PEPCAD V (Paclitaxel Eluting PTCA Balloon in Coronary Artery Disease) trial
Mathey D,
Wendig I,
Borger MA,
Bonaventura K,
Kleber F-X
May 17, 2011
Paclitaxel-eluting balloon angioplasty and cobalt-chromium stents versus conventional angioplasty and paclitaxel-eluting stents in the treatment of native coronary artery stenoses in patients with diabetes mellitus
Ali R,
Degenhardt R,
Zambahari R,
Tresukosol D,
Ahmad W,
bin Haron Kamar H,
Kui-Hian S,
Ong T,
bin Ismail O,
bin Elis S,
Udychalerm W,
Ackermann H,
Borger MA,
Unverdorben M
May 17, 2011
1
Latest news
AHEAD OF PRINT
Robotic-assisted CABG: clinical outcomes
FREE ARTICLE - Aleksander Dokollari et al
November 23, 2023
PCR London Valves 2023
November 16, 2023
NEW ISSUE
PCR London Valves special edition. State-of-the-art on TMVI; the timing of TMVI; direct wire pacing for TMVR; predicting patient-prosthesis mismatch following TAVI and more
November 17, 2023
AHEAD OF PRINT
Pathophysiological CAD patterns predict outcomes post-PCI
FREE ARTICLE - Nozomi Kotoku et al
November 14, 2023
AHEAD OF PRINT
Extra-mitral valve cardiac involvement in MR
FREE ARTICLE - Antonio Popolo Rubbio et al
November 9, 2023
AHEAD OF PRINT
Cardiac damage classification in each AS subtype
FREE ARTICLE - Masaaki Nakase et al
November 6, 2023
AHEAD OF PRINT
CAPTIS embolic protection during TAVR
FREE ARTICLE - Haim D. Danenberg et al
November 2, 2023